http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114306570-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee5cee254d6b538b724902ccfe5202ef |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate | 2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d703023b2ed516eb7af788931f290c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c0effe43c562e8557f740acfe93247 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e45d69613f9e4e6daad446c382bdb6 |
| publicationDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114306570-A |
| titleOfInvention | Effervescent tablet containing procatide and preparation method thereof |
| abstract | The invention discloses an effervescent tablet containing procatide and a preparation method thereof, belonging to the technical field of medicine preparation. The invention provides an effervescent tablet containing procatide, which comprises the following components in parts by weight: 2-4 parts of procatide, 25-50 parts of a foaming agent I, 50-100 parts of a foaming agent II, 1-3 parts of a flavoring agent, 37-112 parts of a filling agent, 3-9 parts of an adhesive and 1-3 parts of a lubricant. The effervescent tablet can disintegrate in water solution or in oral cavity very quickly, and can be dissolved in water and taken for the elderly patients or other patients with swallowing difficulty, so as to greatly improve the medication compliance of patients. The effervescent tablet can generate carbon dioxide gas while disintegrating, helps active ingredients to disperse uniformly and quickly, greatly shortens the time from taking the medicine to acting on gastrointestinal epithelial cells, and has great clinical advantage for patients with chronic idiopathic constipation accompanied with abdominal pain. |
| priorityDate | 2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 178.